CLINICAL_TRIALS
trial_result
· 2025-03-26
Clinical Trial Update: Adalimumab in JIA-associated Uveitis Stopping Trial [Phase 4]
Summary
Phase 4 trial of adalimumab for Juvenile Idiopathic Arthritis-associated uveitis has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nisha Acharya | Conditions: Uveitis, JIA | Phase 4 | Status: COMPLETED | Results posted: 2025-03-26